Imvexxy
Product Images NDC 50261-104

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Imvexxy (NDC 50261-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Imv00 0004 01)

Chemical structure diagram of the active ingredient in IMVEXXY. The illustration shows the molecular arrangement with labeled functional groups and bonds characteristic of a steroidal compound.*

FDA Label Image

Figure 1 (Imv00 0004 02)

Two line graphs comparing serum hormone levels over 24 hours after dosing. The left graph (A) shows estradiol concentrations (pg/mL) over time for 4 mcg, 10 mcg doses, and placebo. The right graph (B) displays estrone concentrations (pg/mL) over time for the same groups. Error bars indicate variability at each time point.*

FDA Label Image

Figure (Imv00 0004 03)

An instructional line drawing showing a person using their hands to open or remove a blister pack of medication tablets. The illustration likely demonstrates how to access the tablets from the packaging, relevant for the oral tablet product IMVEXXY by Mayne Pharma LLC.*

FDA Label Image

Figure (Imv00 0004 04)

An instructional black-and-white line drawing illustrating a hand holding a small, oval-shaped tablet or pill between thumb and forefinger, likely demonstrating proper handling or administration technique.*

FDA Label Image

Figure (Imv00 0004 05)

An instructional line drawing depicting a person's hand inserting an IMVEXXY vaginal suppository. The illustration shows the proper placement inside the vagina.*

FDA Label Image

Figure (Imv00 0004 06)

An instructional line drawing illustration depicting a woman seated on a surface, demonstrating the insertion process of a vaginal tablet using an applicator. The image shows the applicator being placed at the vaginal opening for medication delivery.*

FDA Label Image

Principal Display Panel (Imvexxy 4 mcg 8 Count Carton Label)

Packaging label for IMVEXXY 4 mcg estradiol vaginal inserts, manufactured by Mayne Pharma LLC. The label indicates a prescription-only product containing 8 vaginal inserts. The design features the brand name prominently with dosage strength and usage specification for vaginal application.*

FDA Label Image

Principal Display Panel (Imvexxy 4 mcg 18 Count Carton Label)

IMVEXXY 4 mcg estradiol vaginal inserts packaging label, showing the product name, strength, and dosage form prominently. The label indicates it contains 18 vaginal inserts for vaginal use only, and is marked Rx only. The labeler is Mayne Pharma LLC, with NDC 50261-104-18. Additional information about dosage and contents is included in smaller text.*

FDA Label Image

Principal Display Panel (Imvexxy 10 mcg 8 Count Carton Label)

Packaging label for Imvexxy 10 mcg estradiol vaginal inserts by Mayne Pharma LLC, containing 8 vaginal inserts. The design features the Imvexxy brand in blue and brown text, stating 'Rx only' and 'FOR VAGINAL USE ONLY.' The label also includes manufacturer and distributor information, dosage details, and a barcode.*

FDA Label Image

Principal Display Panel (Imvexxy 10 mcg 18 Count Carton Label)

Packaging label for Imvexxy 10 mcg estradiol vaginal inserts by Mayne Pharma LLC. The label states 'Rx only,' contains 18 vaginal inserts, and designates use for vaginal use only. The label also includes NDC 50261-110-18 and the TherapeuticsMD branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.